Evaluation of intermittent fasting diet in multiple sclerosis

被引：0
|
作者：
Lau, K. L. A. [1 ]
Medvedev, G. [1 ,2 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
[2] Univ British Columbia, New Westminster, BC, Canada
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB1277
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [41] DIET AND MULTIPLE-SCLEROSIS
    SEGALL, E
    LANCET, 1974, 2 (7893): : 1378 - 1379
  • [42] The role of diet in multiple sclerosis
    Konikowska, Klaudia
    Regulska-Ilow, Bozena
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2014, 68 : 325 - 333
  • [43] MULTIPLE-SCLEROSIS AND DIET
    MATHESON, NA
    LANCET, 1974, 2 (7884): : 831 - 831
  • [44] DIET AND MULTIPLE-SCLEROSIS
    TWOMEY, J
    LANCET, 1974, 2 (7890): : 1204 - 1204
  • [45] DIET AND MULTIPLE-SCLEROSIS
    OLSON, WH
    POSTGRADUATE MEDICINE, 1976, 59 (05) : 219 - 221
  • [46] Fatty diet and multiple sclerosis
    de Andres, C
    Lledo, A
    REVISTA DE NEUROLOGIA, 1997, 25 (148) : 2032 - 2035
  • [47] Intermittent fasting with ketogenic diet: A combination approach for management of chronic diseases
    Arora, Niraj
    Pulimamidi, Shruthi
    Yadav, Hariom
    Jain, Shalini
    Glover, Jennifer
    Dombrowski, Keith
    Hernandez, Beverly
    Sarma, Anand Karthik
    Aneja, Rachna
    CLINICAL NUTRITION ESPEN, 2023, 54 : 166 - 174
  • [48] Intermittent fasting
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    Ruelle, Yannick
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2022, (185): : 336 - 336
  • [49] Multiple sclerosis and intermittent self-catheterization
    Jacq, C.
    Hubeaux, K.
    Ramanantsitonta, J.
    PROGRES EN UROLOGIE, 2021, 31 (04): : 195 - 203
  • [50] The Association between Diet and Multiple Sclerosis
    Asgharzadeh, Vahid
    Rezaei, Seyyed Amin Seyyed
    Poor, Behroz Mahdavi
    Asgharzadeh, Mohammad
    Nobari, Hossein Jalaei
    Taghinejad, Zahra
    Kazemi, Abdolhassan
    Rashedi, Jalil
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024, 24 (08) : 909 - 917
12345